YESENIA OCHOA: Open Payments
NPI 1962981787 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 74 payments from 20 companies in 2025. Trend: 2023 $165 · 2024 $100 · 2025 $898
Food & beverage: $878Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $165 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Novo Nordisk Inc | 4 | $72 |
| Ardelyx, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Astellas Pharma US Inc | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
Products named: Kerendia, OTEZLA, GEMTESA, IBSRELA, CAPLYTA, Ozempic, Veozah, REXULTI.
Industry payments across AZ — which companies pay providers there.
